IGC Pharma CEO spouse awarded RSUs, stock
IGC Pharma's CEO and director Ram Mukunda reported indirect transactions involving his spouse's holdings.
Rhea-AI Filing Summary
IGC Pharma's CEO and director Ram Mukunda reported indirect transactions involving his spouse's holdings. On February 3, 2026, his spouse acquired 50,000 shares of common stock at $0.0 per share, bringing indirectly held common stock to 860,752 shares.
On the same date, the spouse was granted 16,667 restricted stock units that vest immediately and 66,666 restricted stock units that vest over time, both indirectly attributed "BY SPOUSE." Each restricted stock unit represents the right to receive one share of IGC common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 16,667 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 66,666 | $0.00 | $0.00 |
| Exercise | Common Stock | 50,000 | $0.00 | $0.00 |
Footnotes (4)
- F1. On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to immediate vesting.
- F2. On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting on March 31, 2026.
- F3. On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting equally over two years starting on March 31, 2026.
- F4. Each restricted stock unit represents a right to receive one share of IGC common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IGC (IGC) report on February 3, 2026?
What restricted stock units were granted to the IGC (IGC) CEO’s spouse?
How do the IGC (IGC) restricted stock units for the CEO’s spouse vest?
Who is identified as the reporting person in the IGC (IGC) Form 4 filing?
What does each IGC (IGC) restricted stock unit represent in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.